TY 2012 Form 990

(A) Name and business address	(B) Description of services	(C) Compensation
JOSH WOODS PRODUCTION, 39 WEST 14TH STREET SUITE 504NEW YORKNY10011	events production	448,921
AAB PRODUCTIONS, 64 ALLEN ROAD 5TH FLOORNEW YORKNY10002	EVENTS PRODUCTION	252,500
GRANT THORNTON LLP, 1901 W MEYERS ROAD SUITE 455OAKBROOK TERRACEIL60181	ACCOUNTING & AUDIT	151,260
THE MORRIS KING COMPANY LLC, 101 FIFTH AVENUE 8TH FLOORNEW YORKNY10003	PUBLIC RELATIONS	148,000
GLOBAL HEALTH INSTITUTE LLC, 5530 WISCONSIN AVENUE SUITE 1255CHEVY CHASEMD20815	PROGRAM DEVELOPMENT	110,368
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 6

Do not include amounts reported on lines 6b, 7b, 8b, 9b, and 10b of Part VIII.	(A) Total expenses	(B) Program service expenses	(C) Management and general expenses	(D) Fundraising expenses
1	Grants and other assistance to governments and organizations in the United States. See Part IV, line 21	3,633,934	3,633,934
2	Grants and other assistance to individuals in the United States. See Part IV, line 22	0
3	Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16	4,363,349	4,363,349
4	Benefits paid to or for members	0
5	Compensation of current officers, directors, trustees, and key employees ....	2,291,708	1,514,295	441,710	335,703
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....	0
7	Other salaries and wages	5,216,798	3,553,662	392,009	1,271,127
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	296,141	199,278	23,426	73,437
9	Other employee benefits .......	1,048,235	668,360	133,335	246,540
10	Payroll taxes ...........	480,922	309,774	56,428	114,720
11	Fees for services (non-employees):
a	Management ......	0
b	Legal .........	185,935	147,812	19,932	18,191
c	Accounting ...........	167,426		167,426
d	Lobbying ...........	62,807	62,807
e	Professional fundraising services. See Part IV, line 17	470,337			470,337
f	Investment management fees ......	164,418		164,418
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) ........	1,298,183	924,659	49,164	324,360
12	Advertising and promotion ....	476,903	473,959	1,184	1,760
13	Office expenses .......	109,631	55,430	7,621	46,580
14	Information technology ......	174,371	128,295	23,985	22,091
15	Royalties ..	0
16	Occupancy ...........	1,231,775	869,859	159,658	202,258
17	Travel ............	836,636	394,275	881	441,480
18	Payments of travel or entertainment expenses for any federal, state, or local public officials ......	0
19	Conferences, conventions, and meetings ....	858,596	746,815	8,077	103,704
20	Interest ...........	8		8
21	Payments to affiliates .......	0
22	Depreciation, depletion, and amortization .....	415,252	293,370	53,847	68,035
23	Insurance ..............	197,026	139,196	25,549	32,281
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	PROGRAM MATERIALS	1,425,070	1,425,070	0	0
b	POSTAGE & SHIPPING	761,994	345,771	5,618	410,605
c	PRINTING	745,975	275,663	745	469,567
d	PROGRAM TECHNICAL SUPPORT	598,873	598,873	0	0
e	All other expenses	1,746,362	818,190	584,862	343,310
25	Total functional expenses. Add lines 1 through 24e	29,258,665	21,942,696	2,319,883	4,996,086
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).	999,371	377,734		621,637

Part X Balance Sheet Check if Schedule O contains a response to any question in this Part X ...............
	1	Cashnon-interest-bearing .............	6,129,973	1	8,001,602
2	Savings and temporary cash investments .........	216,445	2	539,347
3	Pledges and grants receivable, net ...........	203,639	3	205,706
4	Accounts receivable, net .............	3,725,105	4	10,267,012
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
		0	5	0
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
		0	6	0
7	Notes and loans receivable, net .............	0	7	0
8	Inventories for sale or use ..............	75,665	8	133,906
9	Prepaid expenses and deferred charges ..........	705,507	9	1,401,620
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	5,156,241
b	Less: accumulated depreciation .....	10b	3,180,930	1,888,607	10c	1,975,311
11	Investments—publicly traded securities ..........	23,016,384	11	23,656,458
12	Investments—other securities. See Part IV, line 11 .....	4,233,643	12	3,169,232
13	Investments—program-related. See Part IV, line 11 .....	0	13	0
14	Intangible assets ...............	0	14	0
15	Other assets. See Part IV, line 11 ...........	193,227	15	674,143
16	Total assets. Add lines 1 through 15 (must equal line 34)......	40,388,195	16	50,024,337
	17	Accounts payable and accrued expenses .........	1,732,740	17	1,688,090
18	Grants payable .................	1,713,122	18	2,200,512
19	Deferred revenue ................	5,428,345	19	13,321,993
20	Tax-exempt bond liabilities .............	0	20	0
21	Escrow or custodial account liability. Complete Part IV of Schedule D..	0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........	0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..	0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....	0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................	761,884	25	1,681,719
26	Total liabilities. Add lines 17 through 25.........	9,636,091	26	18,892,314
		Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............	21,921,458	27	23,555,115
28	Temporarily restricted net assets ...........	8,493,158	28	7,236,209
29	Permanently restricted net assets ...........	337,488	29	340,699
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........		30
31	Paid-in or capital surplus, or land, building or equipment fund .....		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	30,752,104	33	31,132,023
34	Total liabilities and net assets/fund balances ........	40,388,195	34	50,024,337

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section
4947(a)(1) nonexempt charitable trust.

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E.)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in

section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross

receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of

its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses

acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box that describes the type of supporting organization and complete lines 11e through 11h.

Type I

Type II

Type III - Functionally integrated

Type III - Non-functionally integrated

By checking this box, I certify that the organization is not controlled directly or indirectly by one or more disqualified persons other than foundation managers and other than one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2).

If the organization received a written determination from the IRS that it is a Type I, Type II, or Type III supporting organization, check this box ..................................................

Since August 17, 2006, has the organization accepted any gift or contribution from any of the
following persons?

(i) A person who directly or indirectly controls, either alone or together with persons described in (ii)

Yes

and (iii) below, the governing body of the supported organization? ................

11g(i)

(ii) A family member of a person described in (i) above? ......................

11g(ii)

(iii) A 35% controlled entity of a person described in (i) or (ii) above? ................

11g(iii)

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization in col. (i) listed in your governing document?		(v) Did you notify the organization in col. (i) of your support?		(vi) Is the organization in col. (i) organized in the U.S.?		(vii) Amount of monetary support
(i) Name of supported organization	(ii) EIN	Yes	No	Yes	No	Yes	No	(vii) Amount of monetary support


Total

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2012

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") ....	20,760,601	22,553,697	22,876,129	33,247,849	38,582,579	138,020,855
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......						0
3	The value of services or facilities furnished by a governmental unit to the organization without charge..						0
4	Total. Add lines 1 through 3	20,760,601	22,553,697	22,876,129	33,247,849	38,582,579	138,020,855
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						5,256,686
6	Public support. Subtract line 5 from line 4.						132,764,169

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
7	Amounts from line 4..	20,760,601	22,553,697	22,876,129	33,247,849	38,582,579	138,020,855
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	643,473	668,573	951,963	897,974	755,293	3,917,276
9	Net income from unrelated business activities, whether or not the business is regularly carried on..						0
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)..	155,966	2,756,152	1,735,330	1,624,966	1,467,174	7,739,588
11	Total support (Add lines 7 through 10).						149,677,719

Gross receipts from related activities, etc. (see instructions) ..................

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization, check this box and stop here........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2012 (line 6, column (f) divided by line 11, column (f)) .........

88.700 %

Public support percentage for 2011 Schedule A, Part II, line 14 ...............

90.865 %

16a

33 1/3% support test—2012. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2011. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2012. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2011. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2012

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......
3	Gross receipts from activities that are not an unrelated trade or business under section 513..
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge..
6	Total. Add lines 1 through 5.
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons...
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2012 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2011 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2012 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2011 Schedule A, Part III, line 17 .............

19a

33 1/3% support tests—2012. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ........ right arrow

33 1/3% support tests—2011. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ..... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions ..... right arrow

Schedule A (Form 990 or 990-EZ) 2012

Page 4

Part IV

Supplemental Information. Complete this part to provide the explanations required by Part II, line 10; Part II, line 17a or 17b; and Part III, line 12. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Explanation

Schedule A (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

OMB No. 1545-0047

2012

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, $5,000 or more (in money or
property) from any one contributor. Complete Parts I and II.

Special Rules

For a section 501(c)(3) organization filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi) and received from any one contributor, during the year, a contribution of the
greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 for use exclusively for religious, charitable,
scientific, literary, or educational purposes, or the prevention of cruelty to children or animals. Complete Parts I, II, and
III.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions for use exclusively for religious, charitable, etc., purposes, but these contributions did
not total to more than $1,000. If this box is checked, enter here the total contributions that were received during
the year for an exclusively religious, charitable, etc., purpose. Do not complete any of the parts unless the General Rule
applies to this organization because it received nonexclusively religious, charitable, etc., contributions of $5,000 or more
during the year ......................... Arrow Bullet

Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2 of its Form 990; or check the box on line H of its
Form 990-EZ or on Part I, line 2 of its Form 990-PF, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 2

Name of organization THE FOUNDATION FOR AIDS RESEARCH

Part I	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	RESTRICTED RESTRICTED RESTRICTED RESTRICTED, RESTRICTED RESTRICTED	$RESTRICTED	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 3

Name of organization THE FOUNDATION FOR AIDS RESEARCH

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 4

Name of organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part III

Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet

$
Use duplicate copies of Part III if additional space is needed.

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public
Inspection

If the organization answered “Yes” to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered “Yes” to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered “Yes” to Form 990, Part IV, Line 5 (Proxy Tax) or Form 990-EZ, Part V, line 35c (Proxy Tax), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV.

Political expenditures .................................... SchCMd Bullet

Volunteer hours ........................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ......... SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ...... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............

Yes No

Was a correction made? .........................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ................................... SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b.. SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ..........................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.

For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.

Cat. No. 50084S

Schedule C (Form 990 or 990-EZ) 2012

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......
b	Total lobbying expenditures to influence a legislative body (direct lobbying) .......
c	Total lobbying expenditures (add lines 1a and 1b) ...................
d	Other exempt purpose expenditures ........................
e	Total exempt purpose expenditures (add lines 1c and 1d) ...............
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ......................................	Yes No

4-Year Averaging Period Under Section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the instructions for lines 2a through 2f on page 4.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) Total

2a	Lobbying nontaxable amount

b	Lobbying ceiling amount (150% of line 2a, column(e))

c	Total lobbying expenditures

d	Grassroots nontaxable amount

e	Grassroots ceiling amount (150% of line 2d, column (e))

f	Grassroots lobbying expenditures

Schedule C (Form 990 or 990-EZ) 2012

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each “Yes” response to lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? .........................................

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....

Yes

Media advertisements? ....................................

Mailings to members, legislators, or the public? .........................

Publications, or published or broadcast statements? .......................

Grants to other organizations for lobbying purposes? .......................

Direct contact with legislators, their staffs, government officials, or a legislative body? ........

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......

Other activities? ..........................

Yes

187,171

Total. Add lines 1c through 1i ...............................

187,171

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 .................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ................

Did the organization agree to carry over lobbying and political expenditures from the prior year? ..........

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered “No” OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members .....................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).

Current year .........................................

Carryover from last year ....................................

Total ............................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................

Taxable amount of lobbying and political expenditures (see instructions) ..............

Part IV

Supplemental Information

Complete this part to provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, line 2; and Part ll-B, line 1. Also, complete this part for any additional information.

Identifier	Return Reference	Explanation
Lobbying Expenses	Part II-B	The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool.

Schedule C (Form 990 or 990EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet

Attach to Form 990. SchDMd Bullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate contributions to (during year) ...
3	Aggregate grants from (during year) .....
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements .......................	2a
b	Total acreage restricted by conservation easements ..................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register ....................	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenues included in Form 990, Part VIII, line 1 ........................ SchDMd Bullet

(ii)

Assets included in Form 990, Part X .............................. SchDMd Bullet

$ 149,840

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenues included in Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2012

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other Donated Items, Inventory etc.

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No

If "Yes," explain the arrangement in Part XIII and complete the following table:


c	Beginning balance .................................	1c
d	Additions during the year ..............................	1d
e	Distributions during the year .............................	1e
f	Ending balance ...................................	1f

Did the organization include an amount on Form 990, Part X, line 21? .....................

Yes No

If “Yes,” explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........

Part V

Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	b (c)Two years back	(d)Three years back	(e)Four years back
1a	Beginning of year balance ....	520,804	464,356	561,083	516,826	470,065
b	Contributions ........	3,211	4,341	5,978	8,258	9,378
c	Net investment earnings, gains, and losses	20,742	52,107	-2,705	35,999	37,383
d	Grants or scholarships .....
e	Other expenditures for facilities and programs ........	100,871		100,000
f	Administrative expenses ....
g	End of year balance ......	443,886	520,804	464,356	561,083	516,826

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

Permanent endowment SchDMd Bullet

76.754 %

Temporarily restricted endowment SchDMd Bullet

23.246 %

The percentages in lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations ........................

3a(i)

(ii) related organizations ........................

3a(ii)

If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment. See Form 990, Part X, line 10.

Description of property		(b)Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value
1a	Land .................
b	Buildings ................
c	Leasehold improvements ............	2,101,499	648,256	1,453,243
d	Equipment ................	305,895	249,847	56,048
e	Other .................	2,748,847	2,282,827	466,020
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......				1,975,311

Schedule D (Form 990) 2012

Page 3

Part VII

InvestmentsOther Securities. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)	(b)Book value	(c) Method of valuation: Cost or end-of-year market value
(1)Financial derivatives
(2)Closely-held equity interests
(3)Other (A) BENEFICIAL INTEREST IN TRUST	3,169,232	F








Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)	3,169,232

Part VIII

InvestmentsProgram Related. See Form 990, Part X, line 13.

(a) Description of investment type		(b) Book value	(c) Method of valuation: Cost or end-of-year market value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. See Form 990, Part X, line 15.

(a) Description				(b) Book value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........

Part X

Other Liabilities. See Form 990, Part X, line 25.

1.(a) Description of liability		(b) Book value
Federal income taxes		0
LONG TERM LEASE LIABILITY		1,535,854
SECTION 457 RETIREMENT LIABILITIES		145,865







Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)		1,681,719
2. Fin 48 (ASC 740) Footnote. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII .....................................................

Schedule D (Form 990) 2012

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return
1	Total revenue, gains, and other support per audited financial statements .......			1	29,942,921
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains on investments ..........	2a	-246,161
b	Donated services and use of facilities .........	2b	304,337
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d	-29,887
e	Add lines 2a through 2d .....................			2e	28,289
3	Subtract line 2e from line 1.....................			3	29,914,632
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b.......................			4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......			5	29,914,632

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return
1	Total expenses and losses per audited financial statements ...........			1	29,563,002
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities ..........	2a	304,337
b	Prior year adjustments ..............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d......................			2e	304,337
3	Subtract line 2e from line 1.....................			3	29,258,665
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.......................			4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......			5	29,258,665

Part XIII

Supplemental Information

Complete this part to provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Identifier	Return Reference	Explanation
Endowments	Part V, Line 4	AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors.
FIN 48	Income taxes	Amfar follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement, classification, interest and penalties, and disclosure. As of September 30, 2013, amfar does not believe that there are any uncertain tax positions within its financial statements. Amfar has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ended 2010, 2011, 2012, and 2013 are still open to audit for both federal and state purposes.
Collections of Art, Histocial Treasures, or other similar assets	Part III, Line 4	AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them.
RECONCILIATION OF REVENUE	PART XI, LINE 2D	CHANGE IN VALUE OF THIRD PARTY TRUST ($29,887)

Schedule D (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

General Information on Activities Outside the United States. Complete if the organization answered “Yes” to Form 990, Part IV, line 14b.

For grantmakers. Does the organization maintain records to substantiate the amount of the grants or

assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used to award

the grants or assistance? ...................................

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of grant funds outside
the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(b) Number of offices in the region	(c) Number of employees, agents, and independent contractors in region	(d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in region	(f) Total expenditures for and investments in region
	Central America and the Caribbean			Grantmaking	N/A	177,540
	East Asia and the Pacific	1	19	Grantmaking	N/A	2,604,045
	Europe (Including Iceland and Greenland)			Grantmaking	N/A	656,607
	Middle East and North Africa			Grantmaking	N/A	20,000
	North America			Grantmaking	N/A	150,000
	Russia and the Newly Independent States			Grantmaking	N/A	97,179
	South America			Grantmaking	N/A	249,759
	South Asia			Grantmaking	N/A	56,965
	Sub-Saharan Africa			Grantmaking	N/A	351,253
	East Asia and the Pacific			Program Services	therapeutics research	2,889,590
	Europe (Including Iceland and Greenland)			Fundraising		5,474,457
	North America			Fundraising		435,325
	South America			Fundraising		900,829




3a	Sub-total .....	1	19			14,063,549
b	Total from continuation sheets to Part I ...
c	Totals (add lines 3a and 3b)	1	19			14,063,549

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2012

Schedule F (Form 990) 2012

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered “Yes” to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(d) Purpose of grant	(e) Amount of cash grant	(f) Manner of cash disbursement
Central America and the Caribbean	GMT INITIATIVE	12,000	wire transfe
Central America and the Caribbean	GMT INITIATIVE	17,500	wire transfe
Central America and the Caribbean	GMT INITIATIVE	17,500	wire transfe
Central America and the Caribbean	GMT INITIATIVE	17,500	wire transfe
Central America and the Caribbean	GMT INITIATIVE	14,700	wire transfe
Central America and the Caribbean	GMT INITIATIVE	19,250	wire transfe
Central America and the Caribbean	GMT INITIATIVE	17,500	wire transfe
Central America and the Caribbean	GMT INITIATIVE	17,496	wire transfe
Central America and the Caribbean	GMT INITIATIVE	26,594	wire transfe
Central America and the Caribbean	GMT INITIATIVE	17,500	wire transfe
East Asia and the Pacific	BASIC RESEARCH	15,626	wire transfe
East Asia and the Pacific	BASIC RESEARCH	26,043	wire transfe
East Asia and the Pacific	BASIC RESEARCH	10,000	wire transfe
East Asia and the Pacific	TREAT ASIA	6,330	wire transfe
East Asia and the Pacific	TREAT ASIA	7,690	wire transfe
East Asia and the Pacific	TREAT ASIA	25,637	wire transfe
East Asia and the Pacific	TREAT ASIA	12,250	wire transfe
East Asia and the Pacific	TREAT ASIA	14,250	wire transfe
East Asia and the Pacific	TREAT ASIA	19,110	wire transfe
East Asia and the Pacific	TREAT ASIA	19,050	wire transfe
East Asia and the Pacific	TREAT ASIA	18,180	wire transfe
East Asia and the Pacific	TREAT ASIA	8,170	wire transfe
East Asia and the Pacific	TREAT ASIA	9,150	wire transfe
East Asia and the Pacific	TREAT ASIA	14,250	wire transfe
East Asia and the Pacific	TREAT ASIA	132,059	wire transfe
East Asia and the Pacific	TREAT ASIA	24,042	wire transfe
East Asia and the Pacific	TREAT ASIA	11,494	wire transfe
East Asia and the Pacific	TREAT ASIA	16,177	wire transfe
East Asia and the Pacific	TREAT ASIA	20,529	wire transfe
East Asia and the Pacific	TREAT ASIA	17,576	wire transfe
East Asia and the Pacific	TREAT ASIA	21,445	wire transfe
East Asia and the Pacific	TREAT ASIA	23,404	wire transfe
East Asia and the Pacific	TREAT ASIA	14,459	wire transfe
East Asia and the Pacific	TREAT ASIA	7,695	wire transfe
East Asia and the Pacific	TREAT ASIA	7,087	wire transfe
East Asia and the Pacific	TREAT ASIA	14,009	wire transfe
East Asia and the Pacific	TREAT ASIA	15,843	wire transfe
East Asia and the Pacific	TREAT ASIA	165,747	wire transfe
East Asia and the Pacific	TREAT ASIA	207,232	wire transfe
East Asia and the Pacific	TREAT ASIA	243,438	wire transfe
East Asia and the Pacific	TREAT ASIA	35,051	wire transfe
East Asia and the Pacific	TREAT ASIA	7,125	wire transfe
East Asia and the Pacific	TREAT ASIA	5,550	wire transfe
East Asia and the Pacific	TREAT ASIA	6,525	wire transfe
East Asia and the Pacific	TREAT ASIA	5,175	wire transfe
East Asia and the Pacific	TREAT ASIA	7,500	wire transfe
East Asia and the Pacific	TREAT ASIA	6,450	wire transfe
East Asia and the Pacific	TREAT ASIA	6,900	wire transfe
East Asia and the Pacific	TREAT ASIA	7,350	wire transfe
East Asia and the Pacific	TREAT ASIA	6,300	wire transfe
East Asia and the Pacific	TREAT ASIA	6,225	wire transfe
East Asia and the Pacific	TREAT ASIA	19,586	wire transfe
East Asia and the Pacific	TREAT ASIA	10,499	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	15,150	wire transfe
East Asia and the Pacific	TREAT ASIA	17,524	wire transfe
East Asia and the Pacific	TREAT ASIA	18,900	wire transfe
East Asia and the Pacific	TREAT ASIA	15,800	wire transfe
East Asia and the Pacific	TREAT ASIA	17,850	wire transfe
East Asia and the Pacific	TREAT ASIA	12,900	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	14,775	wire transfe
East Asia and the Pacific	TREAT ASIA	15,050	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	20,000	wire transfe
East Asia and the Pacific	TREAT ASIA	100,000	wire transfe
East Asia and the Pacific	TREAT ASIA	6,747	wire transfe
East Asia and the Pacific	TREAT ASIA	9,433	wire transfe
East Asia and the Pacific	BASIC RESEARCH	286,064	wire transfe
East Asia and the Pacific	TREAT ASIA	34,622	wire transfe
East Asia and the Pacific	TREAT ASIA	41,667	wire transfe
East Asia and the Pacific	TREAT ASIA	36,098	wire transfe
East Asia and the Pacific	TREAT ASIA	150,000	wire transfe
East Asia and the Pacific	TREAT ASIA	19,833	wire transfe
East Asia and the Pacific	TREAT ASIA	6,000	wire transfe
East Asia and the Pacific	TREAT ASIA	6,150	wire transfe
East Asia and the Pacific	TREAT ASIA	9,453	wire transfe
East Asia and the Pacific	TREAT ASIA	26,775	wire transfe
East Asia and the Pacific	TREAT ASIA	19,042	wire transfe
East Asia and the Pacific	TREAT ASIA	11,315	wire transfe
East Asia and the Pacific	GMT INITIATIVE	18,000	wire transfe
East Asia and the Pacific	GMT INITIATIVE	17,000	wire transfe
East Asia and the Pacific	GMT INITIATIVE	18,135	wire transfe
East Asia and the Pacific	TREAT ASIA	15,167	wire transfe
East Asia and the Pacific	TREAT ASIA	40,000	wire transfe
East Asia and the Pacific	TREAT ASIA	15,964	wire transfe
East Asia and the Pacific	TREAT ASIA	15,000	wire transfe
East Asia and the Pacific	TREAT ASIA	5,625	wire transfe
East Asia and the Pacific	TREAT ASIA	5,625	wire transfe
East Asia and the Pacific	TREAT ASIA	5,625	wire transfe
East Asia and the Pacific	TREAT ASIA	11,250	wire transfe
East Asia and the Pacific	TREAT ASIA	11,250	wire transfe
East Asia and the Pacific	TREAT ASIA	15,000	wire transfe
East Asia and the Pacific	TREAT ASIA	11,250	wire transfe
East Asia and the Pacific	TREAT ASIA	15,000	wire transfe
East Asia and the Pacific	TREAT ASIA	79,118	wire transfe
East Asia and the Pacific	TREAT ASIA	15,000	wire transfe
East Asia and the Pacific	TREAT ASIA	9,820	wire transfe
East Asia and the Pacific	TREAT ASIA	5,650	wire transfe
East Asia and the Pacific	TREAT ASIA	14,702	wire transfe
East Asia and the Pacific	TREAT ASIA	39,029	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	26,043	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	39,062	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	10,000	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	90,765	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	159,732	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	120,000	wire transfe
Europe (Including Iceland and Greenland)	BASIC RESEARCH	120,000	wire transfe
Europe (Including Iceland and Greenland)	PUBLIC POLICY	20,000	wire transfe
Europe (Including Iceland and Greenland)	GMT INITIATIVE	14,280	wire transfe
Europe (Including Iceland and Greenland)	GMT INITIATIVE	12,000	wire transfe
Europe (Including Iceland and Greenland)	GMT INITIATIVE	14,920	wire transfe
Europe (Including Iceland and Greenland)	GMT INITIATIVE	15,000	wire transfe
Europe (Including Iceland and Greenland)	GMT INITIATIVE	20,000	wire transfe
Middle East and North Africa	GMT INITIATIVE	20,000	wire transfe
North America	GMT INITIATIVE	20,000	wire transfe
North America	PREVENTION SCIENCE OUTREACH	130,000	wire transfe
Russia and the Newly Independent States	GMT INITIATIVE	12,000	wire transfe
Russia and the Newly Independent States	GMT INITIATIVE	14,982	wire transfe
Russia and the Newly Independent States	GMT INITIATIVE	15,050	wire transfe
Russia and the Newly Independent States	GMT INITIATIVE	14,995	wire transfe
Russia and the Newly Independent States	GMT INITIATIVE	19,952	wire transfe
Russia and the Newly Independent States	GMT INITIATIVE	20,200	wire transfe
South America	GMT INITIATIVE	20,000	wire transfe
South America	GMT INITIATIVE	20,000	wire transfe
South America	GMT INITIATIVE	20,000	wire transfe
South America	GMT INITIATIVE	20,000	wire transfe
South America	GMT INITIATIVE	19,900	wire transfe
South America	GMT INITIATIVE	19,859	wire transfe
South America	GMT INITIATIVE	20,000	wire transfe
South America	GMT INITIATIVE	14,440	wire transfe
South America	GMT INITIATIVE	15,000	wire transfe
South America	GMT INITIATIVE	17,494	wire transfe
South America	GMT INITIATIVE	24,066	wire transfe
South America	PREVENTION SCIENCE OUTREACH	35,000	wire transfe
South Asia	GMT INITIATIVE	11,959	wire transfe
South Asia	TREAT ASIA	13,931	wire transfe
South Asia	TREAT ASIA	18,750	wire transfe
South Asia	TREAT ASIA	18,750	wire transfe
South Asia	TREAT ASIA	5,625	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	15,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	18,500	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	22,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	19,789	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	19,980	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	19,984	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	10,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVE	26,000	wire transfe
Sub-Saharan Africa	PUBLIC POLICY	60,000	wire transfe

Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .... MediumBullet

159

Enter total number of other organizations or entities ....................... MediumBullet

Schedule F (Form 990) 2012

Schedule F (Form 990) 2012Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of non-cash assistance	(g) Description of non-cash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2012

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2012

Page 5

Part V

Supplemental Information
Complete this part to provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).

Identifier	ReturnReference	Explanation
Foreign Activities	Part I, Line 2	International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period.
foreign activities	Part I, Line 3, Column D	The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives.
Foreign Activities - Status of Grantees		The Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 159 charities supported are presumed to be the equivalent of U.S. charities.

Schedule F (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE G (Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information Regarding
Fundraising or Gaming Activities

Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. Form 990-EZ filers are not required to complete this part. right arrow

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.

Indicate whether the organization raised funds through any of the following activities. Check all that apply.

a	Mail solicitations	e	Solicitation of non-government grants
b	Internet and email solicitations	f	Solicitation of government grants
c	Phone solicitations	g	Special fundraising events
d	In-person solicitations

Did the organization have a written or oral agreement with any individual (including officers, directors, trustees

or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?

Yes

If “Yes,” list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.

(i) Name and address of individual or entity (fundraiser)		(ii) Activity	(iii) Did fundraiser have custody or control of contributions?		(iv) Gross receipts from activity	(v) Amount paid to (or retained by) fundraiser listed in col. (i)	(vi) Amount paid to (or retained by) organization
			Yes	No
	aab productions 387 Grant Street Suite K705 New York, NY10002	Fundraising Event/Prod		No	17,864,320	245,067	17,619,253
	john mini consulting inc 707 Savannah Road Lewes, DE199581521	direct mail		No	1,731,016	95,150	1,635,866
	public interest communications 7700 Leesburg Pike Falls Church, VA22043	tele marketing		No	54,024	70,572	-16,548
	Eidolon Communications INc 15 Maiden Lane Suite 1401 New York, NY10038	DIRECT MAIL		No	199,443	47,700	151,743
	telefund inc PO Box 120557 Boston, MA02111	tele marketing		No	18,868	16,231	2,637
	sanky communications inc 589 Eight Avenue 10th Floor New York, NY10018	counseling		No	417,841	102,434	315,407




Total .................					20,285,512	577,154	19,708,358

List all states in which the organization is registered or licensed to solicit funds or has been notified it is exempt from registration or licensing.

AL, AK, AZ, AR, CA, CO, CT, DC, FL, GA, HI, IL, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WV, WI

For Paperwork Reduction Act Notice, see the Instructions for Form 990or 990-EZ.

Cat. No. 50083H

Schedule G (Form 990 or 990-EZ) 2012

Page 2

Part II

Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.

		(a) Event #1 Cannes (event type)	(b) Event #2 Dallas (event type)	(c) Other events 14 (total number)	(d) Total events (add col. (a) through col. (c))
1	Gross receipts . . .	12,526,496	4,507,778	10,408,684	27,442,958
2	Less: Contributions . .	12,085,496	4,407,378	9,592,884	26,085,758
3	Gross income (line 1 minus line 2) . . .	441,000	100,400	815,800	1,357,200
4	Cash prizes . . .	0	0	0	0
5	Noncash prizes . .	0	0	0	0
6	Rent/facility costs . .	746,885	46,894	744,868	1,538,647
7	Food and beverages .	543,201	156,114	228,413	927,728
8	Entertainment . . .
9	Other direct expenses .	3,422,020	2,273,065	3,054,905	8,749,990
10	Direct expense summary. Add lines 4 through 9 in column (d) ...........				11,216,365
11	Net income summary. Combine line 3, column (d), and line 10. ..........				-9,859,165

Part III

Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.

(a) Bingo

(b) Pull tabs/Instant
bingo/progressive bingo

(c) Other gaming

(d) Total gaming (add col.(a) through col.(c))

Gross revenue . . . .

Cash prizes . . . .

Non-cash prizes . . .

Rent/facility costs . . .

Other direct expenses . .

Volunteer labor . . .

	Yes
	No

	Yes
	No

	Yes
	No

Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow

Net gaming income summary. Combine lines 1 and 7 in column (d) .......... right arrow

Enter the state(s) in which the organization operates gaming activities:

Is the organization licensed to operate gaming activities in each of these states? ............

YesNo

If "No," explain:

10a

Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....

YesNo

If "Yes," explain:

Schedule G (Form 990 or 990-EZ) 2012

Page 3

Does the organization operate gaming activities with nonmembers? .................

YesNo

Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity

formed to administer charitable gaming? ..........................

YesNo

Indicate the percentage of gaming activity operated in:

The organization's facility ......................

13a

An outside facility ........................

13b

Enter the name and address of the person who prepares the organization's gaming/special events books and records:

Name

Address

15a

Does the organization have a contract with a third party from whom the organization receives gaming

revenue? ......................................

YesNo

If "Yes," enter the amount of gaming revenue received by the organization right arrow

$ and the

amount of gaming revenue retained by the third party right arrow

$ .

If "Yes," enter name and address of the third party:

Name

Address

Gaming manager information:

Name

Gaming manager compensation right arrow

Description of services provided right arrow

Director/officer Employee Independent contractor

Mandatory distributions:

Is the organization required under state law to make charitable distributions from the gaming proceeds to

retain the state gaming license? ............................

YesNo

Enter the amount of distributions required under state law distributed to other exempt organizations or spent

in the organization's own exempt activities during the tax year right arrow

Part IV

Supplemental Information. Complete this part to provide the explanations required by Part I, line 2b, columns (iii) and (v), and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also complete this part to provide any additional information (see instructions).

Identifier	Return Reference	Explanation
Schedule G, Part I		The Foundation for AIDS Research actually paid out $470,337 in fundraising expenses for the year ending September 30, 2013. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $577,154. Of that $577,154, only $470,337 was paid for fundraising services, the remaining $106,817 was paid for event production services. In the interests of clarity, the foundation would also like to make clear that the compensation reported as having been paid to the professional fundraisers reported on Schedule G is reported on a fiscal year basis. Some of those same fundraisers are reported on the foundation's top 5 highest paid independent contractors list (in Schedule O). In compliance with the instructions to the Form 990, compensation reported for Part VII (and listed in Schedule O) is reported on a calendar year basis. Accordingly, amounts on Part VII and Schedule G will not reconcile.

Schedule G (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number
13-3163817

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC Code section if applicable	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) The Aaron Diamond AIDS Research Center 455 First Avenue 7th Floor New York,NY10016	13-3540234	501(c)(3)	15,626	BASIC RESEARCH
(2) University of California Los Angeles 11000 Kinross Avenue Suite 102 Los Angeles,CA900951406	95-6006143	501(c)(3)	7,143	BASIC RESEARCH
(3) University of California San Francisco 333 California Street Suite 315 San Francisco,CA94118	94-6036493	501(c)(3)	72,000	BASIC RESEARCH
(4) Case Western Reserve University School of Medicin 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501(c)(3)	62,479	BASIC RESEARCH
(5) Aaron Diamond AIDS Research Center 455 First Avenue 7th Floor New York,NY10016	13-3540234	501(c)(3)	62,502	BASIC RESEARCH
(6) New England Primate Research Center Harvard Medic Harvard Medical School 25 Shattuck Southborough,MA01772	04-2103580	501(c)(3)	62,502	BASIC RESEARCH
(7) University of California San Francisco 533 Parnassus Avenue U442 San Francisco,CA94110	94-6036493	501(c)(3)	10,000	BASIC RESEARCH
(8) University of California San Francisco 3333 California Street Suite 315 San Francisco,CA94110	94-6036493	501(c)(3)	10,000	BASIC RESEARCH
(9) University of California San Francisco 3333 California Street Suite 315 San Francisco,CA94110	94-6036493	501(c)(3)	10,000	BASIC RESEARCH
(10) Johns Hopkins University School of Medicine 733 North Boradway Suite 117 Baltimore,MD21287	52-0595110	501(c)(3)	10,000	BASIC RESEARCH
(11) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501(c)(3)	10,000	BASIC RESEARCH
(12) The Salk Institute for Biological Studies 10010 North Torrey Pines Road La Jolla,CA92037	95-2160097	501(c)(3)	10,000	BASIC RESEARCH
(13) Vaccine and Gene Therapy Institute of Florida 11350 SW Village Parkway Port St Lucie,FL34987	36-4631835	501(c)(3)	62,502	BASIC RESEARCH
(14) University of Washington 4333 Brooklyn Avenue NE Box 35947 Seattle,WA981959472	91-6001537	501(c)(3)	62,502	BASIC RESEARCH
(15) Vaccine and Gene Therapy Institute of Florida 11350 SW Village Parkway 3rd Floor Port St Lucie,FL34987	36-4631835	501(c)(3)	62,502	BASIC RESEARCH
(16) Case Western Reserve University 10900 Euclid Avenue LC 4930 Cleveland,OH44106	34-1018992	501(c)(3)	62,502	BASIC RESEARCH
(17) Beth Israel Medical Center Dazian Building First Avenue at 16 New York,NY10003	13-5564934	501(c)(3)	37,646	PUBLIC POLICY
(18) California Institute of Technology 1200 E California Blvd Pasadena,CA91125	95-1643307	501(c)(3)	124,800	BASIC RESEARCH
(19) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501(c)(3)	124,998	BASIC RESEARCH
(20) Massachusetts General Hospital 55 Fruit Street Boston,MA02114	04-2697983	501(c)(3)	124,998	BASIC RESEARCH
(21) Beth Israel Medical Center - Edmond de Rothschild First Avenue at 16th Street New York,NY10003	13-5564934	501(c)(3)	22,500	PUBLIC POLICY
(22) Tulane University 1430 Tulane Avenue EP-15 New Orleans,LA70112	72-0423889	501(c)(3)	33,333	BASIC RESEARCH
(23) John Hopkins University Office of Research Administration Baltimore,MD21205	52-0595110	501(c)(3)	80,000	BASIC RESEARCH
(24) John Hopkins University Office of Research Administration Baltimore,MD21205	52-0595110	501(c)(3)	80,000	BASIC RESEARCH
(25) The Brigham and Women's Hospital Inc 75 Francis Street Boston,MA02115	04-2312909	501(c)(3)	96,397	BASIC RESEARCH
(26) University of North Carolina at Chapel Hill 104 Airport Drive Suite 2200 CB Chapel Hill,NC27599	56-6001393	501(c)(3)	166,748	BASIC RESEARCH
(27) Johns Hopkins University 733 North Broadway Suite 117 Baltimore,MD21205	52-0595110	501(c)(3)	351,225	BASIC RESEARCH
(28) Global Health Committee Inc 200 Longwood Avenue Boston,MA02115	04-3481920	501(c)(3)	297,749	TREAT ASIA
(29) Johns Hopkins University School of Medicine 733 N Broadway Street Broadway Res Baltimore,MD21201	52-0595110	501(c)(3)	46,872	BASIC RESEARCH
(30) Fred Hutchinson Cancer Research Center 1100 Fairview Ave N C2-187 Seattle,WA98109	23-7156071	501(c)(3)	46,872	BASIC RESEARCH
(31) Dana-Farber Cancer Institute Inc 450 Brookline Avenue CLS 1017 Boston,MA02215	04-2263040	501(c)(3)	46,872	BASIC RESEARCH
(32) The Scripps Research Institute 10550 North Torrey Pines Road La Jolla,CA92037	33-0435954	501(c)(3)	46,872	BASIC RESEARCH
(33) Veterans Medical Research Foundation 3350 La Jolla Village Drive MC 151 San Diego,CA92161	33-0189397	501(c)(3)	120,000	BASIC RESEARCH
(34) Universiy of Washington 4333 Brooklyn Ave NE Box 359472 Seattle,WA981959472	91-6001537	501(c)(3)	120,000	BASIC RESEARCH
(35) University of California San Francisco 3333 California Street Suite 315 San Francisco,CA94110	94-6036493	501(c)(3)	114,162	BASIC RESEARCH
(36) Harvard Medical School 25 Shattuck Street Southborough,MA01772	04-2103580	501(c)(3)	119,200	BASIC RESEARCH
(37) Oregon Health and Science University 3181 SW Sam Jackson Park Rd Portland,OR97239	93-1176109	501(c)(3)	120,000	BASIC RESEARCH
(38) Vaccine & Gene Therapy Institute Florida 9801 SW Discovery Way Port St Lucie,FL34987	36-4631835	501(c)(3)	119,990	BASIC RESEARCH
(39) Baron Edmond de Rothschild Chemical Dep First Avenue at 16th Street New York,NY10003	13-5564934	501(c)(3)	67,500	PUBLIC POLICY
(40) AIDS Foundation of Chicago as sponsor of Internati 200 West Jackson Ste 2200 Chicago,IL60606	36-3412054	501(c)(3)	7,500	GMT INITIATIVE
(41) Northwestern University 750 N Lake Shore Drive Chicago,IL60611	36-2167817	501(c)(3)	5,850	BASIC RESEARCH
(42) Johns Hopkins University Bloomberg School of Publi 615 N Wolfe St Baltimore,MD21205	52-0595110	501(c)(3)	48,500	GMT INITIATIVE
(43) Johns Hopkins University Bloomberg School of Publi 615 N Wolfe St Baltimore,MD21205	52-0595110	501(c)(3)	15,107	GMT INITIATIVE
(44) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	116,655	BASIC RESEARCH
(45) Vaccine and Gene Therapy Institute Florida 9801 SW Discovery Way Port St Lucie,FL34987	36-4631835	501(c)(3)	196,761	BASIC RESEARCH
(46) University of California Los Angeles 11000 Kinross Avenue Suite 211 MC Los Angeles,CA90095	95-6006143	501(c)(3)	100,000	BASIC RESEARCH
(47) Johns Hopkins University 733 N Broadway Office of Research Baltimore,MD21205	52-0595110	501(c)(3)	60,000	BASIC RESEARCH
(48) Johns Hopkins University School of Medicine 733 North Broadway Street Baltimore,MD21205	52-0595110	501(c)(3)	20,001	BASIC RESEARCH
(49) Worldwide Orphans Foundation 515 Valley Street Suite 201 Maplewood,NJ07040	13-3968225	501(c)(3)	14,927	TREAT ASIA
(50) Blood Systems Inc dba Blood Systems Research Ins 270 Masonic Avenue San Francisco,CA941184417	86-0098929	501(c)(3)	42,193	BASIC RESEARCH
(51) University of Pittsburgh 123 University Place Pittsburgh,PA152132303	25-0965591	501(c)(3)	102,000	GMT INITIATIVE

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2012

Page 2

Part III

Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a)Type of grant or assistance	(b)Number of recipients	(c)Amount of cash grant	(d)Amount of non-cash assistance	(e)Method of valuation (book, FMV, appraisal, other)	(f)Description of non-cash assistance

Part IV

Supplemental Information.

Complete this part to provide the information required in Part I, line 2, Part III, column (b), and any other additional information.

Identifier	Return Reference	Explanation
Grants and Assistance	Part I, Line 2	amfAR provides grants and fellowships to independent not-for-profit organizations through a peer-review process. Grant applications are first reviewed by the Foundation's volunteer scientific advisory committee, which comprises recognized experts in the medical, scientific, and social sciences disciplines relevant to HIV and AIDS. The scientific advisory committee then sends its evaluations to one of the three committees (research, global initiatives or public policy) of the Foundation's program board, which serves in an advisory capacity to the Board of Trustees. After a program committee has completed its review of the applications, it presents its funding recommendations to amfAR's executive committee and/or the full Board of Trustees for final approval and funding authorization. Grants and fellowships are payable over a one-to-three-year period, and are revocable at amfAR's option if the recipient's performance or use of funds is not consistent with the terms of the grant or fellowships. In certain cases, the actual amounts paid under grants and fellowship awards may be less than the original award if the recipient does not use the full amount awarded. Therefore, a reserve for unexpended grants and fellowships has been recorded. Subawards are grants awarded to not-for-profit organizations to support the costs of collaboration and participation in HIV/AIDS-related research projects for which amfAR has secured restricted funds. Subawards are payable over a one-year period, although advance payments, in full or in part, may be issued following execution of the subaward agreement. Subawards are contingent upon the availability of funds and are revocable if the recipients' performance or use of funds is not consistent with the subaward terms.

Schedule I (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" to Form 990,
Part IV, question 23.
SchJMediumBullet

Attach to Form 990. SchJMediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all officers,
directors, trustees, and the CEO/Executive Director, regarding the items checked in line 1a? .......

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? ................

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 5a or 5b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 6a or 6b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................

If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2012

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(1)Kevin FrostChief Executive Officer	(i) (ii)	385,700 0	0 0	0 0	69,500 0	28,683 0	483,883 0
(2)Bradley JensenASST Treasurer, CFO	(i) (ii)	217,845 0	0 0	0 0	15,470 0	31,319 0	264,634 0
(3)John F Logan JD PhDASST Secretary, VP & GC	(i) (ii)	203,482 0	0 0	0 0	14,331 0	10,201 0	228,014 0
(4)Rowena JohnstonASST Secretary, VP OF RESEARCH	(i) (ii)	166,901 0	0 0	0 0	11,736 0	10,201 0	188,838 0
(5)Edward DonnellyASST Treasurer, ControlleR	(i) (ii)	133,796 0	0 0	0 0	9,796 0	9,043 0	152,635 0
(6)Gregory L BoroffVice President of Development	(i) (ii)	228,217 0	0 0	0 0	16,218 0	10,201 0	254,636 0
(7)Christopher CollinsVice President, Public Policy	(i) (ii)	192,518 0	0 0	0 0	12,720 0	19,636 0	224,874 0
(8)Annette SohnVice President, TREAT Asia	(i) (ii)	200,613 0	0 0	0 0	14,082 0	5,553 0	220,248 0
(9)Eric MuscatellDirector, Philanthropy	(i) (ii)	157,089 0	0 0	0 0	11,276 0	10,201 0	178,566 0
(10)Andrew McInnesDirector, Publications	(i) (ii)	134,850 0	0 0	0 0	9,876 0	31,319 0	176,045 0
(11)Anthony AnconaVice President, Human Resource	(i) (ii)	155,133 0	0 0	0 0	10,935 0	3,276 0	169,344 0
(12)Susan DosterChief Technology Officer	(i) (ii)	132,775 0	0 0	0 0	9,277 0	10,201 0	152,253 0
(13)AnnMarie ShannahanVice President, Public Info	(i) (ii)	194,344 0	0 0	0 0	13,671 0	10,201 0	218,216 0
(14)Bennah SerfatySenior Dir. of Communications	(i) (ii)	120,255 0	0 0	0 0	7,992 0	31,319 0	159,566 0

Schedule J (Form 990) 2012

Page 3

Part III

Supplemental Information

Complete this part to provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.

Identifier	Return Reference	Explanation
Compensation	Part I, Line 4	Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan; however, he did not receive a distribution in 2013.

Schedule J (Form 990) 2012

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE M
(Form 990)

Department of the Treasury

Internal Revenue Service

Noncash Contributions

Complete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image

Attach to Form 990.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Types of Property

	(a) Check if applicable	(b) Number of contributions or items contributed	(c) Noncash contribution amounts reported on Form 990, Part VIII, line 1g	(d) Method of determining noncash contribution amounts
1 Art—Works of art ....	X	1	56,250	appraisal
2 Art—Historical treasures .
3 Art—Fractional interests ..
4 Books and publications ..
5 Clothing and household goods .......
6 Cars and other vehicles ..
7 Boats and planes ....
8 Intellectual property ...
9 Securities—Publicly traded .	X	14	47,853	sales price
10 Securities—Closely held stock .
11 Securities—Partnership, LLC, or trust interests ....
12 Securities—Miscellaneous ..
13 Qualified conservation contribution—Historic structures .....
14 Qualified conservation contribution—Other ...
15 Real estate—Residential .
16 Real estate—Commercial ..
17 Real estate—Other ...
18 Collectibles .....
19 Food inventory ...
20 Drugs and medical supplies .
21 Taxidermy ......
22 Historical artifacts ....
23 Scientific specimens ..
24 Archeological artifacts ...
25 Other ( )
26 Other ( )
27 Other ( )
28 Other ( )

Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement ...

Yes

30a

During the year, did the organization receive by contribution any property reported in Part I, lines 1-28 that it

must hold for at least three years from the date of the initial contribution, and which is not required to be used

for exempt purposes for the entire holding period? ..................

30a

If "Yes," describe the arrangement in Part II.

Does the organization have a gift acceptance policy that requires the review of any non-standard contributions?

Yes

32a

Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash

contributions? ..........................

32a

Yes

If "Yes," describe in Part II.

If the organization did not report an amount in column (c) for a type of property for which column (a) is checked,

describe in Part II.

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 51227J

Schedule M (Form 990) (2012)

Page 2

Part II

Supplemental Information. Complete this part to provide the information required by Part I, lines 30b,
32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.

Identifier	Return Reference	Explanation
Form 990, Schedule M		Line 31: To the extent that amFAR receives non-standard contributions, the organization's policy is to liquidate those items into cash for eventual use in support of the organization's mission. Line 32A: When the organization receives contributions of securities, it uses its investment broker to liquidate those holdings to fund amFAR's various research program activities.

Schedule M (Form 990) (2012)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Identifier	Return Reference	Explanation
Program Service Accomplishments(1)	Part III, Line 4a-4d(1)	Line 4a: Research: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the treatment, prevention, and cure of HIV/AIDS. In 2013, amFAR awarded nearly $4 million in grants and fellowships to support 20 research projects. Cure-Focused Studies The Search for a cure for HIV/AIDS is at the center of amFAR's research efforts. In 2013, through the amFAR Research Consortium on HIV Eradication (ARCHE) program-now in its fourth year of funding-and other targeted grants, the Foundation awarded nearly $3 million for cure-focused research. First Child Cured of HIV At the Conference on Retroviruses and Opportunistic Infections in March 2013, Dr. Deborah Persaud of John Hopkins Children's Center detailed the case of a two-year-old child in Mississippi who had been cured of HIV. Confirmation of the cure was made possible by a grant amFAR awarded to Dr. Persaud and her colleague Dr. Katherine Luzuriaga of the University of Massachusetts Medical School in September 2012. The grant allowed them to establish a research collaboratory to explore and document possible pediatric HIV cure cases. amFAR Research Consortium on HIV Eradication The Foundation launched the ARCHE program in 2010 as a way to leverage the expertise and innovation of distinguished scientists from across the globe to advance cure-focused research. In July, more than $1.4 million in funding went to four collaborative teams of researchers working in the United States, the United Kingdom, France, Thailand, and Australia on studies exploring potential strategies for eliminating HIV infection from the body and characterizing viral reservoirs-which present a major obstacle to a cure. One study, led by Dr. Eric Arts of Case Western Reserve University in Cleveland, Ohio, aims to develop and test a vaccine-like HIV treatment specific to each patient's virus. Unlike other approaches toward an HIV cure that focus on inducing cell changes in all cells that are vulnerable to HIV infection, this treatment specifically targets the infected cells lying dormant in teh viral reservoir. Dr. Arts and Dr. Yong Gao from Case Western is working wiht Drs. Robin Shattock, Sarah Fidler, and Caroline Foster of Imperial College London to study the treatment's effectiveness. In another study, a team led by Dr. Nicolas Chomont of the Vaccine and Gene Therapy Institute in Port St. Lucie, Florida, is studying HIV persistence in T cell subsets during antiretroviral therapy (ART). Specifically, they are investigating the subsets of CD4+ T memory cells-the cells where the HIV reservoir mainly resides-and the roles they may play as a potential target for a cure. Dr. Chomont is working in collaboration with three-time ARCHE grantees Dr. Darah Palmer of University of Sydney, Australia, and Dr. Steven Deeks of the University of California, San Francisco (UCSF); Dr. Jintanat Ananworanich from the Red Cross AIDS Research Centre in Bangkok, Thailand; and Dr. Asier Saez-Cirion of Institut Pasteur in Paris, France. Targeted Grants for HIV Cure Research In February 2013, amfAR awarded eight targeted grants totaling more than $1.4 million to leading researchers from around the world who are working on a variety of cutting-edge, cure-focused studies. These projects include research aimed at therapeutic vaccine development, expanding our understanding of latent viral reservoirs, and examining pharmacological and gene therapy approaches to curing HIV. Dr. Jonah Sacha of the Oregon Health and Science University, in Portland, is examining the macrophage-an immune cell that is closely related to the T cell-for its potential role in maintaining hidden reservoirs of HIV. Dr. Sacha and colleagues propose to directly assess the function of macrophages in viral persistence in a non-human primate model of AIDS. Understanding the macrophage's contribution will guide future approaches to eliminating residual viral reservoirs.
Program Service Accomplishments(2)	Part III, Line 4a-4d (2)	Line 4a, Continued: Although the immune system can greatly reduce levels of virus after infection, it cannot maintain this control indefinitely. Therapeutic vaccines, which are currently being designed and tested, may enable patients to stop taking ART without progressing to disease. Dr. Christian Brander at Irsicaixa AIDS Research Institute, Badalona, Spain, and his colleagues plan to closely monitor changes in immune function after patients-who are currently enrolled in a therapeutic vaccine clinical trial-stop taking their anti-HIV medication. Their findings will help guide the design of more effective therapeutic vaccines and may also enable researchers to predict which individuals will respond best in future trials. Therapeutic vaccines may one day play an important role in achieving sustained remission of HIV. Another study, led by Dr. Satish Pillai at UCSF is examining how an unusual genetic mutation-CCR5-delta32-may enhance the curability of HIV. He will measure the amount of virus that persists in patients with or without this mutation. Applying cutting-edge laboratory techniques, Dr. Pillai's team will compare the size, composition, and decay of the HIV-1 latent reservoir in individuals with and without the mutation. Gene therapy approaches are being investigated as a means of curing HIV. One strategy that has shown promising results uses a gene therapy method to modify a patient's own cells in the laboratory to make them resistant to virus infection. Dr. Rafick-Pierre Skaly, at the Vaccine and Gene Therapy Institute in Port St. Lucie, Florida, will build on the current work being done using this approach to determine if virus becomes undetectable in the blood after stopping ART. He will monitor immune responses, inflammation, and viral reservoirs in a group of patients to ascertain the long-term benefit of this therapy and factors that can improve outcomes of gene therapy and other strategies to cure HIV. Mathilde Krim Fellowships Four researchers received Mathilde Krim Fellowships in Basic Biomedical Research, an initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The initiative has already achieved spectacular results, including numerous published studies in major scientific journals. The 2013 Krim Fellows-each of whom received $125,000-are working on projects focused on HIV/AIDS cure and epidemiological research and vaccine and treatment development. Among the 2013 fellows is Dr. Leopold Kong, Ph.D., of the Scripps Research Institute in California, who will attempt to develop a vaccine using the protective coating of sugar-like molecules that surround the virus. This coating is traditionally thought to hamper the development of antibodies that might form the basis of a vaccine. Dr. Kong will determine whether this protective coat can instead be turned against the virus to render it vulnerable to destruction by the body's immune system. His research will determine if antibodies generated against these sugars can be used to develop a vaccine that can prevent infection. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In the past year, at least 48 scientific publications resulted from amfAR-funded research. Perfecting Tools to Monitor HIV Viral Loads In the March issue of Current Opinion in HIV and AIDS, ARCHE-funded scientist Dr. Sarah Palmer of the University of Sydney, Australia, reviewed the state of knowledge in the detection and monitoring of HIV levels in the blood of infected people. She emphasizes the importance of early ART initiation and the value of monitoring blood HIV RNA levels to ensure the virus is suppressed to below the detection capacity of standard tests. Dr. Palmer goes on to discuss the demand for ultrasensitive virus detection methods and notes that such assays, which can find a single copy of the virus in a milliliter (about a fifth of a teaspoon) of blood, can also be used to document viral "blips," or transient, low-level bursts of virus. She believes these methods will enable researchers to define the source of persistent virus in people on long-term ART, and recently started using the techniques to assess the efficacy of treatment strategies by which latent HIV is chemically coaxed out of a person's infected cells, rendering them vulnerable to attack by ART. Controlling HIV after Stopping Antiretroviral Therapy People with HIV who are successfully treated with ART still have infected cells in which the virus remains silent and invulnerable to attack by the immune system or standard anti-HIV drugs. This is a critical barrier to curing HIV. Several studies show that virus growth quickly returns, in most individuals, within weeks of stopping treatment. In the January issue of the Journal of Infectious Diseases, Dr. Steven Deeks of UCSF, Dr. Una O'Doherty of the University of Pennsylvania, and colleagues described a clinical trial that used a special form of interferon, known as pegylated interferon (PEG-IFN) alpha-2a to suppress the typical rebound in viral growth that occurs after halting ART. They found that 45% of their patients maintained viral loads of less than 400 copies-an amount significantly less than what was expected based on prior treatment interruption studies-when given PEG-IFN in addition to ART before having the ART withdrawn. Four of the subjects had "undetectable" viral loads-less than 48 copies-and stayed off all therapy except the PEG-IFN for a full six months. The authors conclude that they have established "a proof of concept" that HIV growth can be markedly suppressed in people in whom the "detrimental effects of uncontrolled HIV replication on immune function have been partially reversed by ART." Perfecting Gene-Based Therapies Targeting HIV Gene therapy-the use of genetically altered immune cells-is a promising approach to curing HIV/AIDS. However, the cost and potential side effects, which include death, of such an invasive procedure render it inappropriate for most individuals living with HIV. In the April issue of Molecular Therapy, amfAR grantees Dr. Matthew Porteus of Stanford University and Dr. Sara Sawyer of the University of Texas at Austin suggested a safer and potentially more accessible approach-using a person's own genetically modified immune cells. They used an enzyme known as a zinc finger nuclease to insert a cocktail of anti-HIV factors into T cells. The technique mimics the cocktail of anti-HIV drugs used with ART. When all of the factors were present, it provided "virtually complete protection" against infection by the two major strains of HIV-1, R5 and X4. The next step is to perform the same procedure not just in laboratory grown T cells, but in a patient's own immune cells-either T cells or, ultimately, stem cells.
Program Service Accomplishments (3)	Part III, Line 4a-4d (3)	Line 4b: TREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) involves a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 23 adult and 20 pediatric sites throughout the region, which collaborate on a variety of projects. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from more than 8,526 patients at 23 clinical sites in 12 countries. The information gathered and analyzed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. In 2013, the TAHOD network began recruiting participants for a regional study of hepatitis C co-infection among those living with HIV in four countries: Indonesia, Malaysia, Thailand, and Vietnam. The study began with a screening study to assess how many HIV-positive patients in TREAT Asia participating clinics in these countries need to start treatment for hepatitis C. TREAT Asia will then offer up to 200 of these patients hepatitis C treatment for free. The study aims to develop a pilot model of care for treating hepatitis C in resource-limited settings that can be replicated throughout the region, where treatment for the disease is costly and often inaccessible. TREAT Asia Pediatric Network TREAT Asia's Pediatric Network includes 20 sites in seven countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult database, and includes data from approximately 5,030 pediatric patients at 18 clinical sites in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. Adolescent Research In 2013, TREAT Asia conducted several studies on how HIV affects adolescents physically, socially, and emotionally. TREAT Asia's pediatric sites conducted local studies among their adolescent HIV patients to investigate HIV's impact on their health. Among other issues, they assessed cardiovascular function, bone mineral density, incidence of human papillomavirus, models for reproductive healthcare, and optimizing drug adherence. In addition, TREAT Asia is conducting an ongoing study using an audio-computer-assisted survey instrument (ACASI) to better understand how adolescents experience living with HIV by allowing them to anonymously respond to questions using a computer interface about whether they are taking their medicines; if they have tried alcohol, tobacco, or other drugs; their sexual behavior; and stigma they may have experienced at school or at home. Exploring Links Between HIV and Cancer Among HIV-positive MSM, the risk of anal cancer is twice as high compared to those who are HIV-negative, but little research has been done on this issue in Asia. In 2009, using funding from IeDEA, TREAT Asia began supporting an innovative research study exploring the links between HIV and anal cancer and looking at cancer biomarkers in an attempt to better identify MSM with pre-cancerous anal lesions. Research on HPV and anal cancer risk among MSM is ongoing in the three original sites in Bangkok, Bali, and Jakarta. Building Research Capacity TREAT Asia has implemented a research education program to help network members strengthen their skills in conducting clinical research and to boost the overall quality of care in the region. TREAT Asia organized five workshops and training sessions in 2013, including sessions on managing HIV and hepatitis C co-infection, good clinical practices and research ethics, and clinical management of pediatric HIV. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access Communicating treatment information about a disease as complex as HIV/AIDS can be daunting, but patients' lives depend on it. TREAT Asia works closely with regional organizations to support treatment literacy activities, including the production of "community-friendly" educational brochures on HIV treatment standards in local languages. In 2013, TREAT Asia developed a series of educational materials about hepatitis C infection and treatment titled Life Loves the Liver that includes animated video segments, booklets, and flip charts. All materials have been developed in Bahasa Indonesia, Chinese, English, Malay, Thai, and Vietnamese and will be distributed to TREAT Asia's local, national, regional, and global partners. They will also be made available on TREAT Asia's internal webpage and its public YouTube channel. TREAT Asia also continued to publish lay-language articles about new research in the fields of prevention, treatment, and basic science. The goal of these articles is to explain HIV/AIDS research advances for people living with HIV/AIDS and their families, communities, and caregivers across Asia. The articles appear in the TREAT Asia Report and on TREAT Asia's website, www.treatasia.org. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention TREAT Asia was well represented at the conference in June 2013 in Kuala Lumpur, Malaysia. In addition to activities during the main conference, TREAT Asia staff and network investigators participated in pre-conference workshops on HIV pediatric and cure research. At the pediatric workshop, a TREAT Asia study was presented on the correlation between HIV drug levels in hair samples and virus control outcomes, and Dr. Annette Sohn, amfAR vice president and director of the TREAT Asia program, participated in a debate on the need for pre-exposure prophylaxis for youths at risk of HIV. At the main conference, TREAT Asia studies were presented on the long-term impact of perinatally acquired HIV infection and antiretroviral therapy in adolescents, the prevalence of hepatitis B and C co-infections among adults in TREAT Asia's regional HIV research network, and the risk of anal cancer among men who have sex with men in Thailand and Indonesia. 16th Bangkok Symposium on HIV Medicine amfAR continued its sponsorship of this annual regional symposium, which was held in January 2013 in Bangkok. Dr. Sohn spoke about human papillomavirus infection among HIV-infected youths. TREAT Asia also supported a special workshop during the symposium on the challenges faced while transitioning perinatally infected children to adult HIV care.
Program Service Accomplishments (4)	Part III, Line 4a-4d (4)	Line 4c: EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to stimulate broad awareness of the need for better treatment and prevention methods. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policy makers in communicating the need for continued research on HIV/AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 40,000 people; the TREAT Asia Report, published and distributed three times a year to more than 5,000 readers in the international health community; and a monthly e-mail newsletter distributed to more than100,000 people. The Foundation's newly redesigned website features news, interviews, and original articles covering science, policy, the global epidemic, and amfAR programs and activities. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues, and conducts public service advertising campaigns that have been instrumental in educating policymakers, healthcare professionals, people living with HIV/AIDS, and the general public. The Battle of amfAR amfAR helped promote and organize screenings of The Battle of amfAR, a documentary film telling the story of how Swiss scientist Dr. Mathilde Krim and Hollywood movie star Elizabeth Taylor joined forces to create amfAR in 1985. The film played at prominent film festivals throughout 2013 and was an Official Selection at the Sundance and Tribeca Film Festivals. It premiered on HBO in December 2013. Social Media amfAR vigorously expanded its presence in the social media arena, reaching large numbers of people, including a younger demographic that is often less educated about HIV/AIDS. The Foundation regularly added content to its Facebook page, created an Instagram account, and live tweeted and posted images on Instagram from fundraising and program events. amfAR passed 45,000 likes on Facebook in 2013 and now has nearly 20,000 Twitter followers and nearly 6,000 Instagram followers. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR spokespeople-were carried in numerous media outlets, including The New York Times, The Wall Street Journal, The Washington Post, the Associated Press, Reuters, Bloomberg News, CNN, and The Huffington Post. amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. Support of amfAR by prominent public figures began with the late Dame Elizabeth Taylor, and others have followed in her footsteps. amfAR is profoundly grateful for the continuing steadfast support of Global Fundraising Chairman Sharon Stone. In 2013, celebrity supporters included amfAR ambassadors Cheyenne Jackson, Janet Jackson, Milla Jovovich, Liza Minnelli, and Michelle Yeoh, as well as Leonardo DiCaprio, Heidi Klum, Alan Cumming, Aishwarya Rai, Abhishek Bachchan, Ke$ha, Gladys Knight, Jessica Chastain, Dame Shirley Bassey, Hilary Swank, Kylie Minogue, Duran Duran, Rosario Dawson, Rosie Perez, Zachary Quinto, Adrien Brody, Dita Von Teese, Preta Gil, Chelsea Handler, and Carly Rae Jepsen, among many others.
Program Service Accomplishments (5)	Part III, Line 4a-4d (5)	Line 4d: THE GMT INITIATIVE: Since 2007, amfAR has been serving the HIV-related needs of gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR helps expand access to HIV education and prevention services; supports advocacy aimed at increasing funding for prevention and treatment services; and works to end the stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS. Community Awards In 2013, amfAR awarded more than $710,000 to 39 groups in Africa, the Caribbean, Eastern Europe and Central Asia, and Latin America for a wide range of projects addressing HIV prevention, outreach, education, advocacy, testing, research, and capacity building. Sample funded projects include: Africa Men Against AIDS Youth Group (MAAYGO) (Kisumu, Kenya) MAAYGO is conducting a needs assessment among GMT community members, health and social service providers, micro-credit institutions, and employers in order to better understand barriers to economic empowerment and improved health outcomes for GMT. The results of the assessment will be used to increase access to health services by helping health and social service providers to create GMT-friendly environments. In addition, MAAYGO will promote economic independence for GMT through job skills trainings and a GMT-focused micro-credit program. Caribbean Kouraj (Port-au-Prince, Haiti) Kouraj will organize a training program to educate key GMT leaders on human rights. These same leaders will also receive training in basic research techniques so they can conduct a series of interviews with GMT to document and better understand the level of human rights abuses and violence GMT experience. The information collected from these interviews will be analyzed and used to develop a human rights brief that will serve as a tool to advocate for greater inclusion of GMT in national discussions on HIV and health, as well as to advocate for reduced stigma and discrimination against GMT. Eastern Europe and Central Asia Safe Pulse of Youth (SPY) (Belgrade, Serbia) SPY is increasing the number of GMT individuals tested for HIV and other sexually transmitted infections through the use of a mobile testing van and at its drop-in center "BGD Checkpoint." SPY will also strengthen linkages to mental health and social support services for GMT living with HIV in Belgrade and document and disseminate cases of stigma and discrimination experienced by GMT in public and private healthcare institutions. Latin America Asociacin Solidaria Para Impulsar el Desarrollo Humano (ASPI-DH) (San Salvador, El Salvador) In its second year as an amfAR grantee, ASPI-DH will expand its "Open Road 2011" project to additional regions in El Salvador and will continue training healthcare providers at 24 public health centers across the country on the needs of GMT people. ASPI-DH will focus on reducing stigma and discrimination within health centers in an effort to encourage uptake of HIV prevention, treatment, and care for GMT. This will be accomplished by organizing "Open Door" days at the centers that have participated in the trainings. ASPI-DH will also deploy patients as undercover evaluators or mystery clients who will visit the centers in order to evaluate the quality of care. "In Action" Awards The GMT Initiative also made three awards as part of its Advocacy in Action program, which supports GMT-led community-based organizations that wish to influence the policies of governments and external donors. Four awards were made under its Evidence in Action program, which documents and evaluates the impact of community-based programs with the ultimate goal of implementing the most workable strategies for stopping the spread of HIV/AIDS. Evidence in Action was developed with support from ViiV Healthcare's Positive Action Program and the Elton John AIDS Foundation. Awards for these two programs in 2013 totaled approximately $150,000. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations of the spread of HIV among GMT and to advocate for effective strategies to address it, amfAR publishes a range of reports. In May 2013, amfAR published Achieving an AIDS-Free Generation for Gay Men and Other MSM in Southern Africa with the Johns Hopkins Bloomberg School of Public Health. This report details how underfinancing, discrimination, and stigma undermine efforts to address HIV among GMT in the region and makes recommendations about how policymakers can better address the needs of GMT. Individual country profiles on Botswana, Malawi, Namibia, Swaziland, Zambia, and Zimbabwe were also produced to supplement the report. The GMT Initiative Blog, Grassroots, posted articles throughout the year that discuss various HIV-related issues the GMT Initiative's grantee partners are facing and how these issues impact their lives and organizations. Technical Consultation on Innovative Uses of Communication Technology for HIV Programming for MSM and Transgender Populations amfAR co-hosted this meeting in Washington, D.C., May 2-3, 2013, in partnership with the President's Emergency Plan for AIDS Relief (PEPFAR) and USAID. During the meeting, attending activists from around the world were linked with technical leaders and program planners from the U.S. who are working to combat the HIV epidemic among GMT internationally. Prior to the meeting, amfAR hosted a skills-building session for five GMT Initiative grantees that offered them strategies to increase their programs' effectiveness.
Program Service Accomplishments (6)	Part III, Line 4a-4d (6)	Line 4d: Public Policy: Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Capitol Hill Briefings Where Are We in Ending the AIDS Epidemic? An Update on the Science, July 18, 2013 amfAR, along with IDSA Center for Global Health Policy and the Elizabeth Glaser Pediatric AIDS Foundation, co-sponsored two briefings that featured leading researchers discussing the latest research on core evidence-based interventions for achieving an AIDS-free generation. Speakers were Dr. Myron Cohen of the University of North Carolina at Chapel Hill, Dr. Laura Guay from the Elizabeth Glaser Pediatric AIDS Foundation, Dr. Renee Ridzon of Akeso Associates, and Dr. Chris Beyrer of the Johns Hopkins Bloomberg School of Public Health. Prescription Opioids, Heroin and Disease Prevention: Law Enforcement, Research, and Community Perspectives, July 23, 2013 The briefing highlighted the need to overturn the ban on federal funding for syringe services programs (SSPs) in the face of an alarming increase in injection drug use in the United States. SSPs are essential for combating the spread of HIV through the sharing of contaminated needles. A short film produced by amfAR, titled The Exchange (see below), was screened and followed by a discussion of program and policy issues critical to advancing public safety and health. Speakers included Seattle Police Chief Jim Pugel, Dr. Jennifer Havens of the University of Kentucky, and Kristin Dubay Horton of the Bridgeport (CT) Health Department. Harm Reduction As one of the earliest supporters of comprehensive harm reduction programs for people who inject drugs (PWID), including syringe exchange, amfAR has played a leading role in advocating the implementation of these lifesaving HIV prevention programs. Addressing the need to overturn the ban on federal funding for syringe services programs, amfAR produced four short films on the wide-ranging public health and economic benefits of SSPs and launched a new website designed to educate policymakers and the public on the urgent need for these programs. Additionally, amfAR's policy office produced a number of issue briefs and fact sheets addressing HIV among PWID and the value of SSPs to this high-risk population, including a map of SSP coverage in the United States. In July, amfAR hosted a two-day think tank on implementation science for PWID. There are highly effective interventions for preventing HIV transmission and acquisition among PWID, but coverage levels remain low, stymied by counterproductive policy and legal frameworks, as well as by a lack of access to individuals in need of services. Some key points of discussion during the event included using implementation science to increase our understanding of how to reach and retain PWID with currently available programs and technology, efforts to distribute low dead space syringes (which have been shown to reduce HIV and hepatitis C transmission among PWID), and addressing mental illness and social issues surrounding drug use (e.g., homelessness). Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the epidemic in the U.S., where more than one million people are living with the virus. In August, the Public Policy Office contributed an opinion piece to the Huffington Post by amfAR Chairman Kenneth Cole and Rep. Barbara Lee (CA) observing the third anniversary of the National HIV/AIDS Strategy. The editorial summarized progress over the last three years on tackling the AIDS epidemic domestically and called for a renewed commitment by providers, advocates, and policymakers to realize the vision of an AIDS-free generation. Additionally, amfAR produced a number of issue briefs, fact sheets, and infographics showing how cuts to domestic HIV/AIDS programming and research funding through federal sequestration undermine the domestic response to the epidemic. Global Health At the International AIDS Conference in 2012, amfAR released "An Action Agenda to End AIDS," developed with AVAC, to identify major short-term priorities for global AIDS programs together with realistic, annual targets through 2016, in an effort to establish a strong, sustainable foundation for ending AIDS. In 2013, one year after the conference, amfAR produced a follow-up report assessing the world's progress to date. The report describes progress being made in certain key areas, including increases in the total number of people on ART, the amount of pregnant women living with HIV who received antiretroviral medication, the number of men circumcised, and the estimated number of people eligible for ART under new therapy guidelines. The report also identifies areas where the global AIDS response is falling short, including persistent coverage gaps in scaling up core interventions, widespread stigma and discrimination, and inadequate access to key diagnostic tools. Additionally, in 2013, amfAR reported extensively on the impact of budget sequestration on global health, with specific attention to how funding cuts to the President's Emergency Plan for AIDS Relief (PEPFAR)-would undermine the decade's worth of progress made by the largest international response program to the global AIDS epidemic. GMT Gay men, other men who have sex with men, and transgender individuals-collectively referred to as GMT-remain one of the hardest hit and most underserved populations in the global HIV/AIDS epidemic. amfAR's policy office works closely with the Foundation's GMT Initiative to advocate for expanded access to HIV prevention and treatment services for GMT worldwide, and to fight the stigma and discrimination that make GMT more vulnerable to HIV infection and inhibit equal access to care. In May, amfAR released a new report-Achieving an AIDS-Free Generation for Gay Men and Other MSM in Southern Africa-on funding and policy related to tackling the HIV epidemic among gay men and other MSM in Southern Africa (see GMT Initiative). An issue brief released by amfAR in August, titled Tackling HIV/AIDS Among Key Populations: Essential to Achieving an AIDS-Free Generation, argues that ending the AIDS pandemic will not be possible without greatly increased efforts to reduce new infections and prevent AIDS-related deaths among key populations at highest risk of HIV. The brief reports that key populations (including GMT) are severely and disproportionately affected by HIV on a global level-with epidemics among these individuals continuing to grow despite an overall decline in new infection rates-and that they are largely neglected by HIV treatment and prevention efforts as a result (directly and indirectly) of discriminatory laws and policies. The issue brief highlights a few of the evidence-based strategies that are available to substantially reduce the number of new infections and AIDS-related deaths among key populations.
Policies	Form 990, Part VI, Section B	Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. LINE 15 -AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS.
Disclosure	Form 990, Part VI, Section C	LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion.
Functional Expenses	Part IX, Lines 1 & 3	The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F.
Other Changes in Net Assets	FORM 990, SECTION XI, LINE 9	CHANGE IN VALUE OF THIRD PARTY TRUST................ ($29,887) ---------- TOTAL LINE 9 ($29,887) ==========

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2012

Additional Data

Software ID:
Software Version:

1	Briefly describe the organization’s mission or most significant activities: amfar is dedicated to ending the global aids epidemic through innovative research.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	20
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	20
5	Total number of individuals employed in calendar year 2011 (Part V, line 2a) ......	5	91
6	Total number of volunteers (estimate if necessary) .............	6	168
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	33,247,849	38,582,579
9	Program service revenue (Part VIII, line 2g) .........	0	0
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	1,178,972	980,398
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	-7,234,513	-9,648,345
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)...................	27,192,308	29,914,632
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	8,086,344	7,997,283
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	8,864,151	9,333,804
16a	Professional fundraising fees (Part IX, column (A), line 11e).....	491,117	470,337
b	Total fundraising expenses (Part IX, column (D), line 25) 4,996,086
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	11,261,191	11,457,241
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	28,702,803	29,258,665
19	Revenue less expenses. Subtract line 18 from line 12.......	-1,510,495	655,967
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	40,388,195	50,024,337
21	Total liabilities (Part X, line 26).............	9,636,091	18,892,314
22	Net assets or fund balances. Subtract line 21 from line 20.....	30,752,104	31,132,023

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 8,102,469 including grants of $ 4,075,650 ) (Revenue $ 0 )
	RESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the National Institutes of Health. For further details, see Schedule o.

4b	(Code: ) (Expenses $ 6,010,188 including grants of $ 2,581,709 ) (Revenue $ 0 )
	TREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) involves a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 22 adult and 20 pediatric sites throughout the region, which collaborate on a variety of projects. For further details, see Schedule o.

4c	(Code: ) (Expenses $ 3,426,418 including grants of $ 0 ) (Revenue $ 0 )
	EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to stimulate broad awareness of the need for better treatment and prevention methods. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policy makers in communicating the need for continued research on HIV/AIDS. For further details, see Schedule O.

	(Code: ) (Expenses $ 2,363,749 including grants of $ 1,132,282 ) (Revenue $ 0 )
	GMT Initiative

	(Code: ) (Expenses $ 2,039,872 including grants of $ 207,642 ) (Revenue $ 0 )
	public policy

4d	Other program services (Describe in Schedule O.)
	(Expenses $ 4,403,621 including grants of $ 1,339,924 ) (Revenue $ 0 )
4e	Total program service expenses21,942,696

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)
(A) Name and Title
(1) Mathilde Krim PhD........................................................................ Founding Chairman	1.0 .......................	X	X
(2) Kenneth Cole........................................................................ Chairman of the Board	1.0 .......................	X	X
(3) Patricia J Matson........................................................................ Vice Chairman	1.0 .......................	X	X
(4) John C Simons........................................................................ Vice Chairman	1.0 .......................	X	X
(5) Wallace Sheft CPA........................................................................ Treasurer	1.0 .......................	X	X
(6) Mervyn F Silverman MDMPH........................................................................ Secretary	1.0 .......................	X	X
(7) Arlen H Andelson........................................................................ Trustee	1.0 .......................	X
(8) Harry Belafonte........................................................................ Trustee (NON-voting)	1.0 .......................	X
(9) David Bohnett........................................................................ Trustee	1.0 .......................	X
(10) Zev Braun........................................................................ Trustee (non-voting)	1.0 .......................	X
(11) Jonathan S Canno........................................................................ Trustee	1.0 .......................	X
(12) Donald Capoccia........................................................................ Trustee	1.0 .......................	X
(13) R Martin Chavez PhD........................................................................ Trustee	1.0 .......................	X
(14) Jane B Eisner........................................................................ Trustee (NON-voting)	1.0 .......................	X
(15) T Ryan Greenawalt........................................................................ Trustee	1.0 .......................	X
(16) Regan Hofmann........................................................................ Trustee	1.0 .......................	X
(17) Michael J Klingensmith........................................................................ Trustee	1.0 .......................	X

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)				(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(18) Michele V McNeill PharmD........................................................................ Trustee (NON-Voting)	1.0 .......................	X
(19) Edward Milstein........................................................................ Trustee	1.0 .......................	X
(20) Cindy Rachofsky........................................................................ Trustee	1.0 .......................	X
(21) Vincent A Roberti........................................................................ Trustee	1.0 .......................	X
(22) Bill Roedy........................................................................ Trustee	1.0 .......................	X
(23) Alan D Schwartz........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(24) Diana L Taylor........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(25) Kevin Wendle........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(26) Kevin McClatchy........................................................................ Trustee	1.0 .......................	X
(27) Raymond F Schinazi PhD........................................................................ Trustee	1.0 .......................	X
(28) Kevin Frost........................................................................ Chief Executive Officer	40.0 .......................		X			385,700	0	98,183
(29) Bradley Jensen........................................................................ ASST Treasurer, CFO	40.0 .......................		X			217,845	0	46,789
(30) John F Logan JD PhD........................................................................ ASST Secretary, VP & GC	40.0 .......................		X			203,482	0	24,532
(31) Rowena Johnston........................................................................ ASST Secretary, VP OF RESEARCH	40.0 .......................		X			166,901	0	21,937
(32) Edward Donnelly........................................................................ ASST Treasurer, ControlleR	40.0 .......................		X			133,796	0	18,839
(33) Gregory L Boroff........................................................................ Vice President of Development	40.0 .......................			X		228,217	0	26,419
(34) Christopher Collins........................................................................ Vice President, Public Policy	40.0 .......................			X		192,518	0	32,356
(35) Annette Sohn........................................................................ Vice President, TREAT Asia	40.0 .......................			X		200,613	0	19,635
(36) AnnMarie Shannahan........................................................................ Vice President, Public Info	40.0 .......................			X		194,344	0	23,872
(37) Eric Muscatell........................................................................ Director, Philanthropy	40.0 .......................				X	157,089	0	21,477
(38) Andrew McInnes........................................................................ Director, Publications	40.0 .......................				X	134,850	0	41,195
(39) Anthony Ancona........................................................................ Vice President, Human Resource	40.0 .......................				X	155,133	0	14,211
(40) Susan Doster........................................................................ Chief Technology Officer	40.0 .......................				X	132,775	0	19,478
(41) Bennah Serfaty........................................................................ Senior Dir. of Communications	40.0 .......................				X	120,255	0	39,311

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)............	2,623,518	0	448,234

				(A) Total revenue	(B) Related or exempt function revenue	(C) Unrelated business revenue	(D) Revenue excluded from tax under sections 512, 513, or 514
1a	Federated campaigns..1a		461,323
b	Membership dues....1b
c	Fundraising events....1c		26,085,758
d	Related organizations...1d
e	Government grants (contributions)1e		4,641,815

f	All other contributions, gifts, grants, and similar amounts not included above1f		7,393,683

g	Noncash contributions included in lines 1a-1f:$		104,103
h	Total. Add lines 1a-1f.......			38,582,579
			Business Code
2a
b
c
d
e
f	All other program service revenue .
g	Total. Add lines 2a–2f........			0
3	Investment income (including dividends, interest, and other similar amounts).......			708,016			708,016
4	Income from investment of tax-exempt bond proceeds..			0
5	Royalties...........			47,277			47,277
		(i) Real	(ii) Personal
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)	0	0
d	Net rental income or (loss).......			0
		(i) Securities	(ii) Other
7a	Gross amount from sales of assets other than inventory	9,227,075
b	Less: cost or other basis and sales expenses	8,954,693
c	Gain or (loss)	272,382
d	Net gain or (loss)..........			272,382			272,382
8a	Gross income from fundraising events (not including $ 26,085,758 of contributions reported on line 1c). See Part IV, line 18 ..
	a		1,357,200
b	Less: direct expenses ...b		11,216,365
c	Net income or (loss) from fundraising events..			-9,859,165			-9,859,165
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a
b	Less: direct expenses ...b
c	Net income or (loss) from gaming activities...			0
10a	Gross sales of inventory, less returns and allowances .
	a		103,590
b	Less: cost of goods sold ..b		53,569
c	Net income or (loss) from sales of inventory..			157,159			157,159
Miscellaneous Revenue			Business Code
11a	LIST RENTALS		900099	5,477			5,477
b	MISCELLANEOUS INCOME		900099	907			907
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......			6,384
12	Total revenue. See Instructions......			29,914,632			-8,667,947


				(A) Beginning of year		(B) End of year
1	Cashnon-interest-bearing .............			6,129,973	1	8,001,602
2	Savings and temporary cash investments .........			216,445	2	539,347
3	Pledges and grants receivable, net ...........			203,639	3	205,706
4	Accounts receivable, net .............			3,725,105	4	10,267,012
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
				0	5	0
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
				0	6	0
7	Notes and loans receivable, net .............			0	7	0
8	Inventories for sale or use ..............			75,665	8	133,906
9	Prepaid expenses and deferred charges ..........			705,507	9	1,401,620
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	5,156,241
b	Less: accumulated depreciation .....	10b	3,180,930	1,888,607	10c	1,975,311
11	Investments—publicly traded securities ..........			23,016,384	11	23,656,458
12	Investments—other securities. See Part IV, line 11 .....			4,233,643	12	3,169,232
13	Investments—program-related. See Part IV, line 11 .....			0	13	0
14	Intangible assets ...............			0	14	0
15	Other assets. See Part IV, line 11 ...........			193,227	15	674,143
16	Total assets. Add lines 1 through 15 (must equal line 34)......			40,388,195	16	50,024,337
17	Accounts payable and accrued expenses .........			1,732,740	17	1,688,090
18	Grants payable .................			1,713,122	18	2,200,512
19	Deferred revenue ................			5,428,345	19	13,321,993
20	Tax-exempt bond liabilities .............			0	20	0
21	Escrow or custodial account liability. Complete Part IV of Schedule D..			0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........			0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..			0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....			0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................			761,884	25	1,681,719
26	Total liabilities. Add lines 17 through 25.........			9,636,091	26	18,892,314
	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............			21,921,458	27	23,555,115
28	Temporarily restricted net assets ...........			8,493,158	28	7,236,209
29	Permanently restricted net assets ...........			337,488	29	340,699
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........				30
31	Paid-in or capital surplus, or land, building or equipment fund .....				31
32	Retained earnings, endowment, accumulated income, or other funds				32
33	Total net assets or fund balances ...........			30,752,104	33	31,132,023
34	Total liabilities and net assets/fund balances ........			40,388,195	34	50,024,337

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If “Yes,”the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If “Yes,” the organizationmay be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A).......................................	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If "Yes," the organization may be required to file Form 8621, Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713)................................................	Yes	No